Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Epistaxis
- Tranexamic Acid Dosage for Topical Treatment of Anterior Epistaxis
- Epinephrine Nebulization Prior to Nasotracheal Intubation
- Xylometazoline and Cocaine for Nasal Vasoconstriction
- Sirolimus for Nosebleeds in HHT
- Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
- Nebulized Tranexamic Acid in Sinus Surgery
- Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
- The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing
- Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children
- Effect of Practical Demonstration to Use Nasal Spray and Apply Intranasal Ointment on Epistaxis
- NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial
- Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
- Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
- Intranasal TXA for Anterior Epistaxis in the Emergency Department
- Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.
- Pazopanib Effects on Bleeding in Hereditary Hemorrhagic Telangiectasia
- Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
- Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis
- Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)
- Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
- Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department
- Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
- Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
- Intranasal Bevacizumab for HHT-Related Epistaxis
- The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
- Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
- Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
- Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
- North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- Floseal Treatment for Posterior Epistaxis Study
- Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis
- ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome